Phenominer Database Results (56 results)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Clinical Measurement Notes Record ID Study ID
SS.ZUC-Leprfa+/+/Slc serum glucose level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood glucose amount male 126 days 6 124.5 mg/dl 6.4 15.68 serum glucose analysis 0.0 0 101913 2642
SS.ZUC-Leprfa-/-/Slc serum total cholesterol level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood cholesterol amount male 126 days 7 371.14 mg/dl 39.21 103.74 serum total cholesterol measurement test 0.0 0 101920 2642
SS.ZUC-Leprfa+/+/Slc serum low density lipoprotein cholesterol level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood LDL cholesterol amount male 126 days 6 24.0 mg/dl 2.94 7.2 serum low-density lipoprotein-cholesterol measurement test 0.0 0 101921 2642
SS.ZUC-Leprfa-/-/Slc serum low density lipoprotein cholesterol to high density lipoprotein cholesterol ratio fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood cholesterol amount male 126 days 6 1.59 null 0.15 0.37 serum high-density lipoprotein-cholesterol measurement test 0.0 0 ldl/hdl 101926 2642
SS.ZUC-Leprfa+/+/Slc serum aspartate aminotransferase activity level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood aspartate transaminase amount male 126 days 6 57.0 U/l 1.52 3.72 automated blood analysis 0.0 0 101927 2642
SS.ZUC-Leprfa-/-/Slc body weight control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. body mass male 126 days 7 536.92 g 6.98 18.47 body weighing method 0.0 0 101886 2642
SS.ZUC-Leprfa+/+/Slc systolic blood pressure control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. arterial blood pressure trait male 126 days 6 137.7 mmHg 3.04 7.45 tail cuff plethysmography 0.0 0 101889 2642
SS.ZUC-Leprfa-/-/Slc heart rate control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. heart pumping trait male 126 days 7 400.73 beats/min 15.4 40.74 tail cuff plethysmography 0.0 0 101892 2642
SS.ZUC-Leprfa-/-/Slc retroperitoneal fat pad weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. retroperitoneal fat pad mass male 126 days 7 839.28 mg/mm 33.0 87.31 post excision weight measurement 0.0 0 rf/tl 101906 2642
SS.ZUC-Leprfa-/-/Slc serum low density lipoprotein cholesterol level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood LDL cholesterol amount male 126 days 7 73.85 mg/dl 7.15 18.92 serum low-density lipoprotein-cholesterol measurement test 0.0 0 101922 2642
SS.ZUC-Leprfa+/+/Slc urine protein level control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. total urine protein amount male 126 days 6 336.29 mg/d 19.58 47.96 urine protein analysis 0.0 0 101935 2642
SS.ZUC-Leprfa-/-/Slc serum leptin level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood leptin amount male 126 days 7 53.97 ng/ml 2.34 6.19 enzyme linked immunosorbent assay 0.0 0 101912 2642
SS.ZUC-Leprfa-/-/Slc serum alanine aminotransferase activity level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood alanine transaminase amount male 126 days 7 39.25 U/l 2.63 6.96 automated blood analysis 0.0 0 101930 2642
SS.ZUC-Leprfa+/+/Slc serum creatinine level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood creatinine amount male 126 days 6 0.32 mg/dl 0.03 0.07 serum creatinine analysis 0.0 0 101933 2642
SS.ZUC-Leprfa-/-/Slc tibia straight segment length control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. tibia length male 126 days 7 36.47 mm 0.12 0.32 body measuring method 0.0 0 101888 2642
SS.ZUC-Leprfa-/-/Slc heart weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. heart mass male 126 days 7 0.42 g/cm 0.0 0.01 post excision weight measurement 0.0 0 101894 2642
SS.ZUC-Leprfa-/-/Slc heart left ventricle weight to right ventricle weight ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. heart left ventricle mass male 126 days 7 4.74 null 0.12 0.32 post excision weight measurement 0.0 0 lv/rv 101898 2642
SS.ZUC-Leprfa-/-/Slc both kidneys wet weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. kidney mass male 126 days 7 1.29 g/cm 0.04 0.1 post excision weight measurement 0.0 0 101902 2642
SS.ZUC-Leprfa+/+/Slc liver weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. liver mass male 126 days 6 312.19 mg/mm 25.29 61.95 post excision weight measurement 0.0 0 liv/tl 101903 2642
SS.ZUC-Leprfa-/-/Slc liver weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. liver mass male 126 days 7 600.11 mg/mm 42.14 111.49 post excision weight measurement 0.0 0 liv/tl 101904 2642
SS.ZUC-Leprfa+/+/Slc ratio of survivors of metabolic syndrome to total study population during a period of time control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. total life span male 126 days 6 100.0 % necropsy 0.0 0 ratio of survivors of metabolic syndrome to total study population during a period of time (CMO:0003803) 101909 2642
SS.ZUC-Leprfa+/+/Slc tibia straight segment length control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. tibia length male 126 days 6 40.27 mm 0.24 0.59 body measuring method 0.0 0 101887 2642
SS.ZUC-Leprfa+/+/Slc serum leptin level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood leptin amount male 126 days 6 1.67 ng/ml 0.37 0.91 enzyme linked immunosorbent assay 0.0 0 101911 2642
SS.ZUC-Leprfa-/-/Slc serum glucose level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood glucose amount male 126 days 7 136.33 mg/dl 5.27 13.94 serum glucose analysis 0.0 0 101914 2642
SS.ZUC-Leprfa-/-/Slc serum high density lipoprotein cholesterol level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood HDL cholesterol amount male 126 days 7 50.14 mg/dl 2.3 6.09 serum high-density lipoprotein-cholesterol measurement test 0.0 0 101924 2642
SS.ZUC-Leprfa+/+/Slc serum low density lipoprotein cholesterol to high density lipoprotein cholesterol ratio fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood cholesterol amount male 126 days 6 0.89 null 0.09 0.22 serum high-density lipoprotein-cholesterol measurement test 0.0 0 ldl/hdl 101925 2642
SS.ZUC-Leprfa+/+/Slc body weight control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. body mass male 126 days 6 443.75 g 21.62 52.96 body weighing method 0.0 0 101885 2642
SS.ZUC-Leprfa+/+/Slc heart rate control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. heart pumping trait male 126 days 6 417.32 beats/min 13.71 33.58 tail cuff plethysmography 0.0 0 101891 2642
SS.ZUC-Leprfa+/+/Slc heart left atrium weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. heart left atrium mass male 126 days 6 2.06 mg/mm 0.23 0.56 post excision weight measurement 0.0 0 a/tl 101899 2642
SS.ZUC-Leprfa-/-/Slc heart left atrium weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. heart left atrium mass male 126 days 7 2.55 mg/mm 0.14 0.37 post excision weight measurement 0.0 0 a/tl 101900 2642
SS.ZUC-Leprfa+/+/Slc serum total cholesterol level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood cholesterol amount male 126 days 6 116.25 mg/dl 11.59 28.39 serum total cholesterol measurement test 0.0 0 101919 2642
SS.ZUC-Leprfa+/+/Slc serum high density lipoprotein cholesterol level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood HDL cholesterol amount male 126 days 6 26.75 mg/dl 1.11 2.72 serum high-density lipoprotein-cholesterol measurement test 0.0 0 101923 2642
SS.ZUC-Leprfa+/+/Slc serum urea nitrogen level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood urea nitrogen amount male 126 days 6 19.98 mg/dl 1.86 4.56 serum urea nitrogen analysis 0.0 0 101931 2642
SS.ZUC-Leprfa-/-/Slc serum urea nitrogen level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood urea nitrogen amount male 126 days 7 76.21 mg/dl 13.56 35.88 serum urea nitrogen analysis 0.0 0 101932 2642
SS.ZUC-Leprfa-/-/Slc serum creatinine level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood creatinine amount male 126 days 7 1.09 mg/dl 0.19 0.5 serum creatinine analysis 0.0 0 101934 2642
SS.ZUC-Leprfa-/-/Slc creatinine clearance to body weight ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. glomerular filtration trait male 126 days 7 0.18 ml/min/100g 0.02 0.05 urine creatinine analysis 0.0 0 101940 2642
SS.ZUC-Leprfa-/-/Slc ratio of survivors of metabolic syndrome to total study population during a period of time control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. total life span male 126 days 20 35.0 % necropsy 0.0 0 ratio of survivors of metabolic syndrome to total study population during a period of time (CMO:0003803) 101910 2642
SS.ZUC-Leprfa+/+/Slc heart left ventricle weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. heart left ventricle mass male 126 days 6 0.24 g/cm 0.01 0.02 post excision weight measurement 0.0 0 lv/tl 101895 2642
SS.ZUC-Leprfa-/-/Slc heart left ventricle weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. heart left ventricle mass male 126 days 7 0.33 g/cm 0.0 0.01 post excision weight measurement 0.0 0 lv/tl 101896 2642
SS.ZUC-Leprfa+/+/Slc heart left ventricle weight to right ventricle weight ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. heart left ventricle mass male 126 days 6 4.21 null 0.05 0.12 post excision weight measurement 0.0 0 lv/rv 101897 2642
SS.ZUC-Leprfa+/+/Slc inguinal fat pad weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. inguinal fat pad mass male 126 days 6 158.77 mg/mm 27.34 66.97 post excision weight measurement 0.0 0 if/tl 101907 2642
SS.ZUC-Leprfa+/+/Slc serum insulin level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood insulin amount male 126 days 6 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 101915 2642
SS.ZUC-Leprfa-/-/Slc serum aspartate aminotransferase activity level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood aspartate transaminase amount male 126 days 7 67.33 U/l 4.67 12.36 automated blood analysis 0.0 0 101928 2642
SS.ZUC-Leprfa-/-/Slc serum insulin level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood insulin amount male 126 days 7 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 101916 2642
SS.ZUC-Leprfa+/+/Slc serum triglyceride level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood triglyceride amount male 126 days 6 102.25 mg/dl 25.98 63.64 serum triglyceride analysis 0.0 0 101917 2642
SS.ZUC-Leprfa-/-/Slc serum triglyceride level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood triglyceride amount male 126 days 7 1559.93 mg/dl 353.89 936.3 serum triglyceride analysis 0.0 0 101918 2642
SS.ZUC-Leprfa+/+/Slc serum alanine aminotransferase activity level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood alanine transaminase amount male 126 days 6 24.67 U/l 0.88 2.16 automated blood analysis 0.0 0 101929 2642
SS.ZUC-Leprfa-/-/Slc urine protein level control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. total urine protein amount male 126 days 7 735.52 mg/d 93.97 248.62 urine protein analysis 0.0 0 101936 2642
SS.ZUC-Leprfa+/+/Slc creatinine clearance to total kidney weight ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. glomerular filtration trait male 126 days 6 1.25 ml/min/g 0.12 0.29 urine creatinine analysis 0.0 0 101937 2642
SS.ZUC-Leprfa-/-/Slc creatinine clearance to total kidney weight ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. glomerular filtration trait male 126 days 7 0.2 ml/min/g 0.03 0.08 urine creatinine analysis 0.0 0 101938 2642
SS.ZUC-Leprfa+/+/Slc creatinine clearance to body weight ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. glomerular filtration trait male 126 days 6 0.91 ml/min/100g 0.06 0.15 urine creatinine analysis 0.0 0 101939 2642
SS.ZUC-Leprfa-/-/Slc systolic blood pressure control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. arterial blood pressure trait male 126 days 7 210.62 mmHg 2.54 6.72 tail cuff plethysmography 0.0 0 101890 2642
SS.ZUC-Leprfa+/+/Slc both kidneys wet weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. kidney mass male 126 days 6 0.78 g/cm 0.06 0.16 post excision weight measurement 0.0 0 101901 2642
SS.ZUC-Leprfa+/+/Slc retroperitoneal fat pad weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. retroperitoneal fat pad mass male 126 days 6 178.02 mg/mm 31.55 77.28 post excision weight measurement 0.0 0 rf/tl 101905 2642
SS.ZUC-Leprfa-/-/Slc inguinal fat pad weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. inguinal fat pad mass male 126 days 7 795.02 mg/mm 41.33 109.35 post excision weight measurement 0.0 0 if/tl 101908 2642
SS.ZUC-Leprfa+/+/Slc heart weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. heart mass male 126 days 6 0.33 g/cm 0.01 0.04 post excision weight measurement 0.0 0 101893 2642